{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:43:25Z","timestamp":1794411805583,"version":"4.9.0"},"reference-count":56,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atrial fibrillation (AF) is a complex disease requiring a multidomain and (usually) long-term management, thus posing a significant burden to patients with AF, practitioners, and health care system. Unlike cardiovascular conditions with a narrow referral pathway (e.g., acute coronary syndrome), AF may be first detected by a wide range of specialties (often noncardiology) or a general practitioner. Since timely initiated optimal management is essential for the prevention of AF-related complications, a concise and simple guidance is essential for practitioners managing AF patients, regardless of their specialty. Guideline-adherent management of patients with AF has been shown to translate to improved patient outcomes compared with guideline-nonadherent treatment. To facilitate guideline implementation in routine clinical practice, a good guideline document on AF should introduce only evidence-based new recommendations, while avoiding arbitrary changes, which may be confusing to practitioners. Herein, we discuss the main changes in the 2024 European Society of Cardiology (ESC) AF Guidelines relative to the previous 2020 ESC document. Whether the updates and new recommendations issued by the new guidelines will translate in high adherence in clinical practice (and hence improved prognosis of patients with AF) will need to be addressed in upcoming years.<\/jats:p>","DOI":"10.1055\/a-2434-9244","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T23:13:51Z","timestamp":1728342831000},"page":"1087-1094","source":"Crossref","is-referenced-by-count":106,"title":["The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective"],"prefix":"10.1055","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6902","authenticated-orcid":false,"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Intensive Care for Arrhythmias, Cardiology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3788-8942","authenticated-orcid":false,"given":"Giulio F.","family":"Romiti","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sohns","sequence":"additional","affiliation":[{"name":"Clinic for Electrophysiology, Herz-und Diabeteszentrum NRW, Ruhr-Universit\u00e4t Bochum, Med. Fakult\u00e4t OWL (Universit\u00e4t Bielefeld), Bad Oeynhausen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"G Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euv269","article-title":"Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry","volume":"17","author":"G Y Lip","year":"2015","journal-title":"Europace"},{"issue":"36","key":"ref3","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"I C Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"e007411","DOI":"10.1161\/CIRCOUTCOMES.120.007411","article-title":"Integrated care in atrial fibrillation: a road map to the future","volume":"14","author":"A Bhat","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"38","key":"ref5","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/europace\/euab092","article-title":"The atrial fibrillation better care pathway for managing atrial fibrillation: a review","volume":"23","author":"D Stevens","year":"2021","journal-title":"Europace"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"e29408","DOI":"10.2196\/29408","article-title":"Cost-effectiveness of mobile health-based integrated care for atrial fibrillation: model development and data analysis","volume":"24","author":"X Luo","year":"2022","journal-title":"J Med Internet Res"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.amjmed.2018.06.012","article-title":"Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (atrial fibrillation better care) pathway","volume":"131","author":"M Proietti","year":"2018","journal-title":"Am J Med"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/europace\/euaa274","article-title":"Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry","volume":"23","author":"M Proietti","year":"2021","journal-title":"Europace"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12916-022-02526-7","article-title":"Clinical complexity and impact of the ABC (atrial fibrillation better care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry","volume":"20","author":"G F Romiti","year":"2022","journal-title":"BMC Med"},{"issue":"13","key":"ref11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Y Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejim.2020.09.024","article-title":"Mobile health technology-supported atrial fibrillation screening and integrated care: a report from the mAFA-II trial long-term extension cohort","volume":"82","author":"Y Guo","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018atrial fibrillation better care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"101757","DOI":"10.1016\/j.eclinm.2022.101757","article-title":"Adherence to the atrial fibrillation better care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: a post-hoc analysis from the prospective GLORIA-AF Registry","volume":"55","author":"G F Romiti","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"e2140071","DOI":"10.1001\/jamanetworkopen.2021.40071","article-title":"The effects of implementing a mobile health-technology supported pathway on atrial fibrillation-related adverse events among patients with multimorbidity: the mAFA-II randomized clinical trial","volume":"4","author":"Y Yao","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","volume":"123","author":"G F Romiti","year":"2023","journal-title":"Thromb Haemost"},{"issue":"31","key":"ref19","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/eurheartj\/ehac265","article-title":"A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO consortium","volume":"43","author":"S P Johnsen","year":"2022","journal-title":"Eur Heart J"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"J A Joglar","year":"2024","journal-title":"Circulation"},{"issue":"09","key":"ref21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"E D Borre","year":"2018","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCEP.111.966713","article-title":"Reliable identification of \u201ctruly low\u201d thromboembolic risk in patients initially diagnosed with \u201clone\u201d atrial fibrillation: the Belgrade atrial fibrillation study","volume":"5","author":"T S Potpara","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"27","author":"D Brieger","year":"2018","journal-title":"Heart Lung Circ"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"T F Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"J G Andrade","year":"2020","journal-title":"Can J Cardiol"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese Expert Consensus Guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary","volume":"124","author":"Y Wang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?","volume":"137","author":"P B Nielsen","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"A J Wagstaff","year":"2014","journal-title":"QJM"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"B Corica","year":"2024","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/STROKEAHA.116.015900","article-title":"Do women with atrial fibrillation experience more severe strokes? Results from the Austrian Stroke Unit Registry","volume":"48","author":"C Lang","year":"2017","journal-title":"Stroke"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1038\/s41467-024-51193-0","article-title":"Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort","volume":"15","author":"P B Nielsen","year":"2024","journal-title":"Nat Commun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"100967","DOI":"10.1016\/j.lanepe.2024.100967","article-title":"Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","volume":"43","author":"K Teppo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"20","key":"ref35","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"K Teppo","year":"2024","journal-title":"Eur Heart J"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"e14107","DOI":"10.1111\/eci.14107","article-title":"Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation","volume":"54","author":"K Teppo","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"ref38","first-page":"899","article-title":"Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark","volume":"38","author":"K Gadsb\u00f8ll","year":"2017","journal-title":"Eur Heart J"},{"issue":"08","key":"ref39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/mja18.00646","article-title":"National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"209","author":"D Brieger","year":"2018","journal-title":"Med J Aust"},{"issue":"19","key":"ref40","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"A J Camm","year":"2010","journal-title":"Eur Heart J"},{"issue":"21","key":"ref41","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"A J Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1636534","article-title":"Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS-BLED scores with an approach focused on modifiable bleeding risk factors","volume":"118","author":"T F Chao","year":"2018","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1160\/TH17-10-0710","article-title":"Assessing bleeding risk in atrial fibrillation patients: comparing a bleeding risk score based only on modifiable bleeding risk factors against the HAS-BLED Score. The AMADEUS trial","volume":"117","author":"M A Esteve-Pastor","year":"2017","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.amjmed.2017.09.009","article-title":"Comparing bleeding risk assessment focused on modifiable risk factors only versus validated bleeding risk scores in atrial fibrillation","volume":"131","author":"Y Guo","year":"2018","journal-title":"Am J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2017.11.025","article-title":"Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study","volume":"254","author":"T F Chao","year":"2018","journal-title":"Int J Cardiol"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"D A Gorog","year":"2022","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref47","first-page":"991","article-title":"Clinical outcomes of patients with atrial fibrillation who survived from bleeding event: the results from COOL-AF Thailand registry","volume":"124","author":"A Winijkul","year":"2024"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1161\/STROKEAHA.117.019183","article-title":"Predicting major bleeding in ischemic stroke patients with atrial fibrillation","volume":"48","author":"N A Hilkens","year":"2017","journal-title":"Stroke"},{"issue":"04","key":"ref49","first-page":"739","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a \u2018real world\u2019 nationwide cohort study","volume":"106","author":"J B Olesen","year":"2011","journal-title":"Thromb Haemost"},{"issue":"23","key":"ref50","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"C T January","year":"2014","journal-title":"Circulation"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"euae035","DOI":"10.1093\/europace\/euae035","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"T Potpara","year":"2024","journal-title":"Europace"},{"issue":"14","key":"ref52","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"P Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1055\/a-1807-0336","article-title":"Early rhythm control and the risks of ischemic stroke, heart failure, mortality, and adverse events when performed early (<3 months): a nationwide cohort study of newly diagnosed patients with atrial fibrillation","volume":"122","author":"T F Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"15","key":"ref54","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"C Sohns","year":"2023","journal-title":"N Engl J Med"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"N F Marrouche","year":"2018","journal-title":"N Engl J Med"},{"issue":"13","key":"ref56","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"P Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"J S Healey","year":"2024","journal-title":"N Engl J Med"},{"issue":"13","key":"ref58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"W F McIntyre","year":"2024","journal-title":"Circulation"},{"issue":"15","key":"ref59","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"M D Cabana","year":"1999","journal-title":"JAMA"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2434-9244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:30:55Z","timestamp":1732663855000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2434-9244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,11,26]]},"published-print":{"date-parts":[[2024,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2434-9244","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10,7]]},"published":{"date-parts":[[2024,10,7]]}}}